CDC Advisory Panel Backs Pfizer Covid Vaccine For Kids 12 To 15 – Update

CDC Advisory Panel Backs Pfizer Covid Vaccine For Kids 12 To 15 – Update
Updated with CDC news: A CDC advisory council voted Wednesday to back the use of the Pfizer-BioNTech coronavirus vaccine for adolescents age 12 to 15.

The Advisory Committee on Immunization Practices, a group of medical and public health experts, voted 14 in favor, with one recusal, paving the way for the organization to officially green light the two-dose vaccine. The Fda approved the use for that age group on Monday.

Previously: The U.S. Food and Drug Administration has expanded the emergency use authorization for the Pfizer-BioNTech Covid-19 vaccine to include children ages 12-to-15 years-old.

That expands the Dec. 11, 2020 use authorization for people 16 and older, and at the same dosage. It means a much bigger swathe of the U.S. population can be vaccinated — including middle schoolers before next September rolls around.

The Fda called the expansion “a significant step in the fight against the Covid-19 pandemic.” The agency is holding a
See full article at Deadline »

Similar News


Recently Viewed